Whitehawk Therapeutics, Inc. (WHWK) income statement
WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.07−0.05 (-1.60%)
Close on Nov 20, 2026Market cap $175.02MP/E –Yield –
Whitehawk Therapeutics, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -21.8%
Financial strength
- Current ratio
- 17.38
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 770.0%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.96
- Dividend yield
- –
See a number that looks wrong?